[Bevacizumab associated with radiotherapy and temozolomide as a first line treatment for high-grade gliomas: one answer but too many questions].

Lebrun-Frenay, C

[Bevacizumab associated with radiotherapy and temozolomide as a first line treatment for high-grade gliomas: one answer but too many questions]. / Le bévacizumab dans le traitement des gliomes de haut grade : une réponse et beaucoup de questions.

Lebrun-Frenay, C.

Affiliation

Lebrun-Frenay C; Service de neurologie, fédération de neuro-oncologie, hôpital Pasteur, 30, voie Romaine, 06002 Nice, France. Electronic address: lebrun-frenay.c@chu-nice.fr.

Rev Neurol (Paris) ; 170(4): 235-6, 2014 Apr.

Article in Fr | MEDLINE | ID: mdl-24776742

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Antineoplastic Agents, Alkylating/therapeutic use; Brain Neoplasms/therapy; Chemoradiotherapy; Dacarbazine/analogs & derivatives; Glioma/therapy; Bevacizumab; Chemoradiotherapy/adverse effects; Dacarbazine/therapeutic use; Humans; Temozolomide

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Agents, Alkylating / Angiogenesis Inhibitors / Dacarbazine / Antibodies, Monoclonal, Humanized / Chemoradiotherapy / Glioma Type of study: Risk_factors_studies Limits: Humans Language: Fr Journal: Rev Neurol (Paris) Year: 2014 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google